Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine

The eighteen page case study work of Batu Biologics published by Impact Journals.

Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax™

The nine page pre-clinical work of Batu Biologics published by the Journal of Translational Medicine.

ValloVax Safety Rationale and Pilot Study Case Report

The twelve page case study work of Batu Biologics published by the Journal of Translational Medicine.

Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?

An eleven page review published by the Journal of Translational Medicine.

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy

A nine page review published by the Journal of Translational Medicine.

TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant

An eleven page review published by the Journal of Translational Medicine.

Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization

A nine page review published by Elsevier under Molecular Immunology.